US20020035071A1
(en)
*
|
1997-07-08 |
2002-03-21 |
Josef Pitha |
Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
|
US8563522B2
(en)
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
US20060116330A1
(en)
*
|
1997-07-08 |
2006-06-01 |
The Iams Company |
Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
|
US7029702B2
(en)
*
|
1998-07-07 |
2006-04-18 |
Ritter Natural Sciences Llc |
Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
|
ID29150A
(id)
*
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
EP1212066A4
(en)
*
|
1999-08-09 |
2004-03-03 |
Univ Maryland |
PROINTESTINAL MATURATION AND ANTI-INFLAMMATORY EFFECTS OF LACTOBACILLUS AS WELL AS PROTEINS, CARBOHYDRATES AND LIPIDS SECRETED BY LACTOBACILLUS
|
EP1409010A4
(en)
*
|
2000-07-03 |
2005-06-29 |
Probendo Pty Ltd |
TREATMENT OF endotoxemia AND OF DISORDERS ASSOCIATED BY OF PROBIOTICS
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
CA2342040C
(en)
*
|
2000-09-21 |
2012-07-10 |
Kyowa Hakko Kogyo Co., Ltd. |
Anaerobic bacterium as a drug for cancer gene therapy
|
AU2058702A
(en)
|
2000-10-06 |
2002-04-15 |
Nestle Sa |
Use of probiotic lactic acid bacteria for balancing the skin's immune system
|
IT1320772B1
(it)
*
|
2000-11-02 |
2003-12-10 |
Proge Farm Srl |
Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
|
ATE508198T1
(de)
*
|
2001-02-01 |
2011-05-15 |
Yakult Honsha Kk |
Verfahren zur beurteilung des ausmasses, in dem in lebensmitteln und getränken mit vergorener milch vorhandenes bifidobacterium in den darm gelangt
|
AU2002249531A1
(en)
*
|
2001-04-02 |
2002-10-28 |
Alimentary Health Limited |
Immunotherapy based on dendritic cells
|
JP4671384B2
(ja)
*
|
2001-05-15 |
2011-04-13 |
雪印乳業株式会社 |
新規乳酸菌株
|
EP1264893A1
(en)
*
|
2001-06-08 |
2002-12-11 |
Teagasc Dairy Products Research Centre |
CLA biosynthesis by bifidobacteria
|
PE20030284A1
(es)
*
|
2001-07-26 |
2003-05-01 |
Alimentary Health Ltd |
Cepas de bifidobacterium
|
PE20030274A1
(es)
*
|
2001-07-26 |
2003-05-08 |
Alimentary Health Ltd |
Cepas de lactobacillus salivarius
|
JP5116194B2
(ja)
*
|
2001-09-04 |
2013-01-09 |
株式会社ヤクルト本社 |
炎症性腸疾患予防治療剤
|
CA2457092A1
(en)
*
|
2001-09-05 |
2003-03-20 |
Vsl Pharmaceuticals, Inc. |
Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
|
GB0124580D0
(en)
*
|
2001-10-12 |
2001-12-05 |
Univ Reading |
New composition
|
DE60210497T2
(de)
*
|
2001-12-07 |
2006-11-23 |
Morinaga Milk Industry Co. Ltd. |
Bifidobacterium longum
|
US6941649B2
(en)
*
|
2002-02-05 |
2005-09-13 |
Force10 Networks, Inc. |
Method of fabricating a high-layer-count backplane
|
DE10206995B4
(de)
*
|
2002-02-19 |
2014-01-02 |
Orthomol Pharmazeutische Vertriebs Gmbh |
Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
|
JP2005537236A
(ja)
*
|
2002-06-13 |
2005-12-08 |
ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド,コーク |
プロバイオティック治療
|
US8168170B2
(en)
|
2002-10-03 |
2012-05-01 |
The Procter And Gamble Company |
Compositions having an inner core and at least three surrounding layers
|
IL152127A0
(en)
|
2002-10-06 |
2003-05-29 |
Bio Balance Corp |
Probiotic compositions for the treatment of inflammatory bowel disease
|
US7105336B2
(en)
*
|
2002-10-07 |
2006-09-12 |
Biogaia Ab |
Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
|
US7179460B2
(en)
*
|
2002-12-05 |
2007-02-20 |
Danisco A/S |
Bacterial composition and its use
|
US7740838B2
(en)
*
|
2002-12-05 |
2010-06-22 |
Danisco A/S |
Bacterial composition and its use
|
JP2004189672A
(ja)
*
|
2002-12-11 |
2004-07-08 |
Gen Corp:Kk |
抗下痢症組成物
|
US20040208863A1
(en)
*
|
2003-01-30 |
2004-10-21 |
James Versalovic |
Anti-inflammatory activity from lactic acid bacteria
|
SE526711C2
(sv)
*
|
2003-01-31 |
2005-10-25 |
Probi Ab |
Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
|
US20040197304A1
(en)
|
2003-04-01 |
2004-10-07 |
The Procter & Gamble Company And Alimentary Health, Ltd. |
Methods of determining efficacy of treatments of inflammatory diseases of the bowel
|
US20040265279A1
(en)
*
|
2003-05-08 |
2004-12-30 |
Timothy Dinan |
Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
|
US7731976B2
(en)
*
|
2003-08-29 |
2010-06-08 |
Cobb And Company, Llp |
Treatment of irritable bowel syndrome using probiotic composition
|
US20060177424A1
(en)
*
|
2003-08-29 |
2006-08-10 |
Cobb Mark L |
Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
|
US7759105B2
(en)
*
|
2003-08-29 |
2010-07-20 |
Cobb & Company, Llp |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
US8192733B2
(en)
*
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
US7749509B2
(en)
*
|
2003-08-29 |
2010-07-06 |
Cobb And Company, Llp |
Treatment of autism using probiotic composition
|
GB0323039D0
(en)
*
|
2003-10-01 |
2003-11-05 |
Danisco |
Method
|
US20050238631A1
(en)
*
|
2003-12-04 |
2005-10-27 |
Steve Burwell |
Methods and compositions for preventing biofilm formation, reducing existing biofilms, and for reducing populations of bacteria
|
US8877178B2
(en)
*
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
US20050152884A1
(en)
|
2003-12-19 |
2005-07-14 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria globosum
|
US8894991B2
(en)
|
2003-12-19 |
2014-11-25 |
The Iams Company |
Canine probiotic Lactobacilli
|
US20050158294A1
(en)
*
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
US7785635B1
(en)
|
2003-12-19 |
2010-08-31 |
The Procter & Gamble Company |
Methods of use of probiotic lactobacilli for companion animals
|
WO2005072718A1
(ja)
*
|
2004-01-28 |
2005-08-11 |
Kurume University |
乳清発酵物を含有する医薬組成物
|
US7862808B2
(en)
*
|
2004-07-01 |
2011-01-04 |
Mead Johnson Nutrition Company |
Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
|
WO2006012536A2
(en)
*
|
2004-07-22 |
2006-02-02 |
Ritter Andrew J |
Methods and compositions for treating lactose intolerance
|
KR100568036B1
(ko)
|
2004-08-12 |
2006-04-07 |
하남주 |
장기능 활성화 및 면역기능 강화작용을 하는비피도박테리움 균주 및 이를 함유하는 생균제제
|
JP2006166829A
(ja)
*
|
2004-12-17 |
2006-06-29 |
Best Ecology:Kk |
アイスサプリメント及びその製造方法
|
WO2006097949A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Actial Farmacêutica, Lda. |
Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
|
AU2011205121B2
(en)
*
|
2005-04-08 |
2012-07-05 |
Alimentary Health Ltd |
Method of use of orally administered probiotic bifidobacteria for human beauty benefits
|
EP1865795A1
(en)
|
2005-04-08 |
2007-12-19 |
Alimentary Health Limited |
Methods of use of orally administered probiotic bifidobacteria for human beauty benefits
|
US20060228448A1
(en)
|
2005-04-11 |
2006-10-12 |
The Iams Company |
Pet food compositions comprising two components
|
US7303745B2
(en)
|
2005-04-15 |
2007-12-04 |
Bristol-Myers Squibb Company |
Method for preventing or treating the development of respiratory allergies
|
WO2006130188A1
(en)
*
|
2005-05-31 |
2006-12-07 |
The Iams Company |
Feline probiotic bifidobacteria
|
EP2270131A1
(en)
|
2005-05-31 |
2011-01-05 |
The Iams Company |
Feline probiotic lactobacilli
|
US20090035288A1
(en)
*
|
2005-07-20 |
2009-02-05 |
Ruud Albers |
Edible product containing beneficial bacteria
|
ITMI20051510A1
(it)
*
|
2005-08-02 |
2007-02-03 |
Proge Farm Srl |
Uso di specifici batteri lattici per la preparazione di composizioni iunomodulanti
|
RU2297835C1
(ru)
*
|
2005-09-26 |
2007-04-27 |
Закрытое акционерное общество "Партнер" |
Препарат для лечения неинфекционных воспалительных болезней кишечника
|
WO2007038466A2
(en)
*
|
2005-09-27 |
2007-04-05 |
Cobb & Company |
Treatment of bipolar disorder utilizing anti-fungal compositions
|
US7943328B1
(en)
|
2006-03-03 |
2011-05-17 |
Prometheus Laboratories Inc. |
Method and system for assisting in diagnosing irritable bowel syndrome
|
US20090170772A1
(en)
*
|
2006-03-31 |
2009-07-02 |
Morinaga Milk Industry Co., Ltd. |
Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
|
WO2007133188A1
(en)
*
|
2006-05-01 |
2007-11-22 |
Cobb & Company, Llp |
Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
|
US20080085524A1
(en)
|
2006-08-15 |
2008-04-10 |
Prometheus Laboratories Inc. |
Methods for diagnosing irritable bowel syndrome
|
WO2008053444A2
(en)
|
2006-11-01 |
2008-05-08 |
The Procter & Gamble Company |
Treating a respiratory condition with bifidobacterium
|
US7964238B2
(en)
*
|
2007-01-29 |
2011-06-21 |
Guardian Industries Corp. |
Method of making coated article including ion beam treatment of metal oxide protective film
|
RU2436581C2
(ru)
|
2007-02-01 |
2011-12-20 |
Дзе Иамс Компани |
Способ уменьшения воспаления и снижения стресса у млекопитающего
|
BRPI0721254A2
(pt)
*
|
2007-02-22 |
2013-01-15 |
Juergen Schrezenmeir |
medicamento para a profilaxia, supressço ou eliminaÇço de reaÇÕes alÉrgicas, medicamento para a troca de balanÇo th1-th2 no corpo humano em direÇço a uma aumento de th1 e/ou a reduÇço de th2, mÉtodo para o preparo de um medicamento para a profilaxia, supressço ou eliminaÇço de reaÇÕes alÉrgicas em humanos, mÉtodo para a produÇço de um medicamento para a troca de balanÇo th1-th2 no corpo humano em direÇço a um aumento de th1 e/ou a uma reduÇço de th2, uso de bactÉria gram-positiva, probiàtica tais como, lactobacilos e bifidobactÈria, e alimento ou suplemento de alimento
|
WO2008106373A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Mead Johnson Nutrition Company |
Product containing inactivated probiotic for children or infants
|
KR20090109131A
(ko)
*
|
2007-03-27 |
2009-10-19 |
더 프록터 앤드 갬블 캄파니 |
생균제를 투여하기 위한 방법 및 키트
|
CN101688171B
(zh)
*
|
2007-03-28 |
2013-03-27 |
营养健康有限公司 |
益生双歧杆菌菌株
|
MY146595A
(en)
*
|
2007-03-28 |
2012-08-30 |
Alimentary Health Ltd |
Probiotic bifidobacterium strains
|
CN101835806B
(zh)
*
|
2007-05-04 |
2012-11-07 |
营养健康有限公司 |
外泌多糖
|
EP2522358B1
(en)
|
2007-06-27 |
2016-11-09 |
Laboratorios Ordesa, S.l. |
Peptides against rotavirus infection
|
JP2009057346A
(ja)
*
|
2007-09-03 |
2009-03-19 |
Kirin Holdings Co Ltd |
免疫バランス調節用組成物
|
FR2921795B1
(fr)
*
|
2007-10-03 |
2011-04-29 |
Gervais Danone Sa |
Utilisation d'une souche de bifidobacterium,pour la preparation d'une composition destinee a la prevention et/ou au traitement de manifestations de type allergique
|
US20100310522A1
(en)
*
|
2007-11-26 |
2010-12-09 |
Plant Bioscience Limited |
Novel Polypeptides Having Endolysin Activity and Uses Thereof
|
US20110223248A1
(en)
*
|
2007-12-12 |
2011-09-15 |
Ritter Pharmaceuticals, Inc. |
Methods and compositions for treating lactose intolerance
|
ES2395838T3
(es)
*
|
2007-12-21 |
2013-02-15 |
Compagnie Gervais Danone |
Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium
|
ES2343499B1
(es)
*
|
2007-12-24 |
2011-06-10 |
Consejo Superior De Investigaciones Cientificas |
Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
|
EP2110028A1
(en)
|
2008-04-15 |
2009-10-21 |
Nestec S.A. |
Bifidobacterium longum and hippocampal BDNF expression
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
EP2293802A4
(en)
*
|
2008-06-25 |
2011-11-09 |
Ritter Pharmaceuticals Inc |
LACTOSE COMPOSITIONS HAVING REDUCED LACTOSE CONTENT
|
US9232813B2
(en)
*
|
2008-07-07 |
2016-01-12 |
The Iams Company |
Probiotic supplement, process for making, and packaging
|
CN102089422B
(zh)
*
|
2008-07-11 |
2013-07-17 |
科.汉森有限公司 |
新的益生长双歧杆菌
|
RU2453320C2
(ru)
*
|
2008-08-05 |
2012-06-20 |
Виктор Владимирович Чалов |
Композиция для перорального применения, содержащая непатогенные микроорганизмы, обладающая способностью нормализовать микрофлору кишечника (варианты)
|
US20100233320A1
(en)
*
|
2008-09-11 |
2010-09-16 |
Gregory Dean Sunvold |
Animal Feed Kibble with Protein-Based Core and Related Methods
|
US20100074870A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Bristol-Myers Squibb Company |
Probiotic infant products
|
KR101057357B1
(ko)
|
2008-09-22 |
2011-08-17 |
광주과학기술원 |
유산균 및 콜라겐을 유효성분으로 포함하는 관절염 예방 또는 치료용 약제학적 조성물 및 식품 조성물
|
AU2009315298A1
(en)
*
|
2008-11-11 |
2010-05-20 |
Alimentary Health Limited |
Bifidobacterium longum
|
WO2010098822A1
(en)
|
2009-02-24 |
2010-09-02 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
GB0908949D0
(en)
|
2009-05-26 |
2009-07-01 |
Plant Bioscience Ltd |
Novel polypeptides having endolysin activity and uses thereof
|
US20100330151A1
(en)
|
2009-06-25 |
2010-12-30 |
Mary Elaine Freeland |
Method of Promoting Gastrointestinal Health Using a Combination of a Probiotic Microorganism and Chocolate
|
US20110027412A1
(en)
*
|
2009-07-31 |
2011-02-03 |
Kris Eugene Spence |
Compositions and Methods for Promoting Gastrointestinal and/or Cardiovascular Health
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
TR201807143T4
(tr)
|
2009-08-25 |
2018-06-21 |
Nestec Sa |
Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
|
WO2011027829A1
(ja)
*
|
2009-09-02 |
2011-03-10 |
京都府公立大学法人 |
乳酸菌由来のrnaを有効成分とする組成物
|
EP3260126A1
(en)
*
|
2009-10-09 |
2017-12-27 |
Prothera, Inc. |
Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease
|
RU2557310C2
(ru)
*
|
2009-11-11 |
2015-07-20 |
Алиментари Хелс Лимитед |
ШТАММ Bifidobacterium longum, ПРИГОДНЫЙ ДЛЯ ПРИМЕНЕНИЯ В ИММУНОМОДУЛЯЦИИ, ИНДУКЦИИ ПРОДУКЦИИ ЦИТОКИНОВ, ЛЕЧЕНИИ АУТОИММУННОГО ЗАБОЛЕВАНИЯ, КОНТРОЛЕ ОТНОШЕНИЯ IL - 10:IL - 12, И ЕГО ИСПОЛЬЗОВАНИЕ
|
CN102946891B
(zh)
*
|
2009-11-11 |
2017-09-01 |
营养健康有限公司 |
益生菌双歧杆菌菌株
|
CN102905712B
(zh)
|
2010-01-28 |
2015-12-16 |
Ab-生物学有限公司 |
用于治疗肠炎的益生菌组合物
|
HRP20220751T1
(hr)
|
2010-02-01 |
2022-09-02 |
Rebiotix, Inc. |
Bakterioterapija clostridium difficile kolitisa
|
FR2955774A1
(fr)
|
2010-02-02 |
2011-08-05 |
Aragan |
Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
|
JP5852558B2
(ja)
*
|
2010-03-26 |
2016-02-03 |
株式会社明治 |
腸管免疫の抑制剤のスクリーニング方法
|
RU2451741C2
(ru)
*
|
2010-04-26 |
2012-05-27 |
Татьяна Александровна Левченко |
ШТАММ Bifidobacterium longum АБД-3, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ БИФИДОСОДЕРЖАЩЕЙ ПРОДУКЦИИ
|
RU2451740C2
(ru)
*
|
2010-04-26 |
2012-05-27 |
Татьяна Александровна Левченко |
ШТАММ Bifidobacterium longum АБД-7, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ БИФИДОСОДЕРЖАЩЕЙ ПРОДУКЦИИ
|
EP2563372A4
(en)
*
|
2010-04-28 |
2013-10-02 |
Ritter Pharmaceuticals Inc |
PREBIOTIC FORMULATIONS AND METHODS OF USE
|
WO2011148219A1
(en)
*
|
2010-05-28 |
2011-12-01 |
Compagnie Gervais Danone |
Probiotic strains for use in improving the enteric nervous system
|
CN102269858A
(zh)
|
2010-06-02 |
2011-12-07 |
北京智朗芯光科技有限公司 |
自动聚焦***和自动聚焦方法
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性t細胞の増殖または集積を誘導する作用を有する組成物
|
FR2962045B1
(fr)
*
|
2010-07-05 |
2012-08-17 |
Bifinove |
Complexe macromoleculaire d'origine bacterienne et utilisation dudit complexe moleculaire pour prevenir et traiter les rhumatismes inflammatoires
|
NZ607043A
(en)
|
2010-08-04 |
2015-05-29 |
Borody Thomas J |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
US8877179B2
(en)
|
2010-11-11 |
2014-11-04 |
Nestec S.A. |
Frozen confections containing probiotic micro-organisms
|
EP2481299B1
(en)
|
2011-01-31 |
2016-12-07 |
Dr. Fischer Gesundheitsprodukte GmbH |
Bifidobacterium bifidum strains for application in gastrointestinal diseases
|
EP3135291A1
(en)
|
2011-03-09 |
2017-03-01 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
WO2012140636A1
(en)
|
2011-04-11 |
2012-10-18 |
Alimentary Health Limited |
A probiotic formulation
|
RU2460777C1
(ru)
*
|
2011-04-21 |
2012-09-10 |
Общество с ограниченной ответственностью "Бифилюкс" |
Штамм bifidobacterium longum, используемый для получения бифидосодержащей продукции
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
KR101355440B1
(ko)
|
2011-10-26 |
2014-02-05 |
주식회사한국야쿠르트 |
류마티스 관절염 예방 효능을 갖는 락토바실러스 헬베티쿠스 에이취와이7801 및 이를 유효성분으로 함유하는 제품
|
CN103131647B
(zh)
*
|
2011-11-29 |
2017-06-27 |
上海上药信谊药厂有限公司 |
婴儿双歧杆菌及其制剂
|
CN104160014A
(zh)
|
2011-12-01 |
2014-11-19 |
国立大学法人东京大学 |
诱导调节性t细胞的增殖或积累的人源细菌
|
JP5468183B2
(ja)
*
|
2011-12-28 |
2014-04-09 |
株式会社山田養蜂場本社 |
IgA産生促進作用を有する新規乳酸菌及びその用途
|
WO2013107913A1
(en)
|
2012-01-19 |
2013-07-25 |
University College Cork - National University Of Ireland, Cork |
Gaba-producing culturable bacteria derived from the human gastrointestinal tract
|
CN110201003A
(zh)
|
2012-02-29 |
2019-09-06 |
伊西康内外科公司 |
微生物区系的组合物及与其相关的方法
|
DK2830599T3
(da)
|
2012-03-29 |
2018-10-08 |
Therabiome Llc |
Site-specifikke gastrointestinale orale vaccineformuleringer med virkning på ileum og appendix
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
JP2015526469A
(ja)
|
2012-08-20 |
2015-09-10 |
ボリス, マルコシアンMarkosian, Boris |
癌に対する胎盤ワクチン接種療法
|
FR2999601B1
(fr)
*
|
2012-12-17 |
2015-01-30 |
Urgo Lab |
Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
|
CN105120847B
(zh)
|
2013-03-14 |
2018-12-28 |
塞拉拜姆有限责任公司 |
益生生物和/或治疗剂的靶向胃肠道递送
|
KR101434220B1
(ko)
*
|
2013-03-26 |
2014-08-28 |
삼육대학교산학협력단 |
다제내성균에 대한 저해 활성을 갖는 신규 유산균
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
EP3375447A1
(en)
|
2013-06-05 |
2018-09-19 |
Rebiotix, Inc. |
Microbiota restoration therapy (mrt), compositions and methods of manufacture
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9511100B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9694039B2
(en)
|
2013-06-05 |
2017-07-04 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US10383901B2
(en)
|
2013-06-05 |
2019-08-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
GB2535034A
(en)
|
2013-07-21 |
2016-08-10 |
Whole Biome Inc |
Methods and systems for microbiome characterization, monitoring and treatment
|
US20150209392A1
(en)
|
2014-01-24 |
2015-07-30 |
The Procter & Gamble Company |
Filaments Comprising a Microorganism and Method for Making Same
|
JP2017511708A
(ja)
|
2014-01-24 |
2017-04-27 |
ザ プロクター アンド ギャンブル カンパニー |
微生物含有繊維要素を含むウェブ及びその作製方法
|
US20150209468A1
(en)
|
2014-01-24 |
2015-07-30 |
The Procter & Gamble Company |
Hygiene article containing microorganism
|
SG11201703395PA
(en)
|
2014-10-31 |
2017-05-30 |
Whole Biome Inc |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
KR102523805B1
(ko)
|
2014-12-23 |
2023-04-20 |
4디 파마 리서치 리미티드 |
면역 조정
|
EP3400953A1
(en)
|
2014-12-23 |
2018-11-14 |
4D Pharma Research Limited |
Pirin polypeptide and immune modulation
|
CA2975217C
(en)
|
2015-02-13 |
2023-08-15 |
Mars, Incorporated |
Pet food feeding system
|
EP3288394A4
(en)
|
2015-04-28 |
2019-01-23 |
Mars, Incorporated |
PROCESS FOR THE PREPARATION OF A STERILIZED WASTE FOOD PRODUCT
|
EP3294307A4
(en)
|
2015-05-14 |
2019-01-23 |
Crestovo Holdings Llc |
COMPOSITIONS FOR TRANSPLANTATION OF FECAL FLORA AND METHODS OF PREPARATION AND USE THEREOF, AND DEVICES FOR THEIR ADMINISTRATION
|
NZ776366A
(en)
|
2015-05-22 |
2023-02-24 |
Univ Minnesota |
Methods for treating autism spectrum disorder and associated symptoms
|
CN107847530A
(zh)
|
2015-06-01 |
2018-03-27 |
芝加哥大学 |
通过控制共生微生物丛来治疗癌症
|
US20160354507A1
(en)
|
2015-06-07 |
2016-12-08 |
The Procter & Gamble Company |
Article of commerce containing absorbent article
|
US10799539B2
(en)
|
2015-06-09 |
2020-10-13 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10905726B2
(en)
|
2015-06-09 |
2021-02-02 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
CN107921072A
(zh)
|
2015-06-09 |
2018-04-17 |
雷柏奥提斯有限公司 |
微生物群恢复治疗(mrt)组合物和制造方法
|
US10828340B2
(en)
|
2015-06-09 |
2020-11-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
EA201890048A1
(ru)
|
2015-06-15 |
2018-06-29 |
4Д Фарма Рисёрч Лимитед |
Композиции, содержащие бактериальные штаммы
|
EA201890050A1
(ru)
|
2015-06-15 |
2018-06-29 |
4Д Фарма Рисёрч Лимитед |
Композиции, содержащие бактериальные штаммы
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
EA038405B1
(ru)
|
2015-06-15 |
2021-08-24 |
4Д Фарма Рисёрч Лимитед |
ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ШТАММЫ БАКТЕРИИ Bifidobacterium breve, ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПАТОЛОГИЧЕСКОГО СОСТОЯНИЯ, ОПОСРЕДОВАННОГО IL-17 ИЛИ Th17
|
US20170020750A1
(en)
|
2015-07-23 |
2017-01-26 |
The Procter & Gamble Company |
Patch containing microorganism
|
EP3341081B1
(en)
|
2015-08-27 |
2020-11-11 |
PrecisionBiotics Group Limited |
Use of bifidobacterium longum and an exopolysaccharide produced thereby
|
CN108135946A
(zh)
|
2015-08-27 |
2018-06-08 |
宝洁公司 |
长双歧杆菌
|
JP2018534277A
(ja)
|
2015-10-05 |
2018-11-22 |
シュヴァイツェリッシェ フォルシュングスインスティテュート フュア ホーフゲブリクスクリーマ ウント メディツィン イン ダヴォス |
炎症性状態を治療するためのアッカーマンシア・ムシニフィラ(Akkermansia muciniphila)の使用
|
NZ742787A
(en)
|
2015-11-20 |
2020-02-28 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
DK3313423T3
(da)
|
2016-03-04 |
2019-05-20 |
4D Pharma Plc |
Sammensætninger omfattende bakterielle blautia-stammer til behandling af visceral hypersensitivitet
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
WO2017152072A1
(en)
*
|
2016-03-04 |
2017-09-08 |
California Institute Of Technology |
New germanosilicate compositions and methods of preparing the same
|
RU2659240C2
(ru)
*
|
2016-05-23 |
2018-06-29 |
федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный университет" (КемГУ) |
Способ получения функционального продукта питания для реабилитации онкологических больных
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
TW201821093A
(zh)
|
2016-07-13 |
2018-06-16 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
WO2018071537A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
US11213549B2
(en)
|
2016-10-11 |
2022-01-04 |
Finch Therapeutics Holdings Llc |
Compositions and method for treating primary sclerosing cholangitis and related disorders
|
IT201600121481A1
(it)
*
|
2016-11-30 |
2018-05-30 |
Sintal Dietetics Srl |
L. salivarius sgl03: attività probiotiche e produzione di proteine antimicrobiche
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
CN107043705A
(zh)
*
|
2016-12-30 |
2017-08-15 |
大连医科大学 |
用于建立临床营养菌种资源库的益生菌筛选方法
|
CN116676222A
(zh)
*
|
2017-01-31 |
2023-09-01 |
庆熙大学校产学协力团 |
新型乳酸菌及其用途
|
EP3589726A1
(en)
|
2017-02-28 |
2020-01-08 |
Alimentary Health Limited |
Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
|
WO2018187464A1
(en)
|
2017-04-05 |
2018-10-11 |
Crestovo Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
CA3058818A1
(en)
|
2017-04-05 |
2018-10-11 |
Crestovo Holdings Llc |
Compositions and methods for treating parkinson's disease (pd) and related disorders
|
MA48940A
(fr)
|
2017-05-22 |
2020-04-08 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
MA41708A
(fr)
|
2017-05-24 |
2020-04-08 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
JP2020521760A
(ja)
|
2017-05-26 |
2020-07-27 |
クレストヴォ・ホールディングス・エルエルシー |
糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法
|
HUE052319T2
(hu)
|
2017-06-14 |
2021-04-28 |
4D Pharma Res Ltd |
Baktériumtörzseket tartalmazó készítmények
|
WO2018229236A2
(en)
|
2017-06-14 |
2018-12-20 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
AR112328A1
(es)
|
2017-07-05 |
2019-10-16 |
Evelo Biosciences Inc |
Composiciones y métodos para tratamiento de cáncer usando bifidobacterium animalis ssp. lactis
|
CA3072032A1
(en)
*
|
2017-08-07 |
2019-02-14 |
Finch Therapeutics, Inc. |
Compositions and methods for maintaining and restoring a healthy gut barrier
|
AU2018326705A1
(en)
|
2017-08-30 |
2020-03-05 |
Pendulum Therapeutics, Inc. |
Methods and compositions for treatment of microbiome-associated disorders
|
RU2665173C1
(ru)
*
|
2017-09-18 |
2018-08-28 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Оренбургский государственный медицинский университет" Министерства здравоохранения Российской Федерации |
Способ профилактики атопического дерматита у младенцев путем модуляции микробного механизма гистаминообразования
|
JPWO2019087842A1
(ja)
*
|
2017-11-01 |
2020-11-12 |
ビオフェルミン製薬株式会社 |
非ステロイド性抗炎症薬及びプロトンポンプ阻害薬誘発性小腸障害の予防又は治療剤
|
KR102024883B1
(ko)
|
2017-11-24 |
2019-09-24 |
주식회사 고바이오랩 |
락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도
|
DK3517119T3
(da)
|
2018-01-26 |
2021-11-15 |
Probisearch S L U |
Sammensætning omfattende ny lactobacillus salivarius-stamme og fremgangsmåde til forebyggelse og behandling af otitis og infektioner i de øvre luftveje
|
ES2933999T3
(es)
*
|
2018-01-29 |
2023-02-15 |
Prec Group Limited |
Un producto combinado para la profilaxis y el tratamiento del síndrome del intestino irritable
|
US20190298783A1
(en)
*
|
2018-03-28 |
2019-10-03 |
Morinaga Milk Industry Co., Ltd. |
Composition for relieving stress, pharmaceutical composition and food and drink composition and method for relieving stress using the composition for relieving stress
|
RU2670054C1
(ru)
*
|
2018-04-24 |
2018-10-17 |
Федеральное государственное бюджетное учреждение науки Институт клеточного и внутриклеточного симбиоза Уральского отделения Российской академии наук |
Штамм бактерий Bifidobacterium bifidum ICIS-310 - продуцент ингибитора провоспалительного цитокина INF-γ
|
CA3099668C
(en)
|
2018-05-09 |
2023-10-03 |
Kobiolabs, Inc |
Lactobacillus paracasei strain and use thereof
|
CN110468061B
(zh)
*
|
2018-05-11 |
2024-03-08 |
韩国亿诺生物有限公司 |
具有预防或治疗癌症的效果的新型菌株
|
KR102138834B1
(ko)
|
2018-05-23 |
2020-07-29 |
주식회사 고바이오랩 |
락토바실러스 가세리 kbl697 균주 및 그 용도
|
CN112236154A
(zh)
*
|
2018-05-31 |
2021-01-15 |
深圳华大生命科学研究院 |
一种组合物及其应用
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
CN109486700A
(zh)
*
|
2018-08-31 |
2019-03-19 |
石家庄君乐宝乳业有限公司 |
副干酪乳杆菌n1115预防结肠炎的应用及相应的益生菌粉、应用
|
WO2020069280A1
(en)
|
2018-09-27 |
2020-04-02 |
Crestovo Holdings Llc |
Compositions and methods for treating epilepsy and related disorders
|
ES2752798B2
(es)
*
|
2018-10-05 |
2020-08-12 |
Consejo Superior Investigacion |
Cepa de Bifidobacterium longum sub. infantis y uso de la misma
|
KR102074445B1
(ko)
|
2018-12-12 |
2020-02-06 |
주식회사 비피도 |
류마티스관절염 개선, 예방 또는 치료를 위한 비피도박테리움 롱검 rapo 균주 및 이를 포함하는 조성물
|
WO2021021765A1
(en)
*
|
2019-07-26 |
2021-02-04 |
Evolve Biosystems, Inc. |
Nutritive compositions with bioactive proteins
|
KR102224072B1
(ko)
*
|
2019-08-19 |
2021-03-10 |
주식회사 빙그레 |
면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도
|
CN110547915A
(zh)
*
|
2019-08-29 |
2019-12-10 |
云南白药清逸堂实业有限公司 |
应用益生菌的卫生棉制品及其制备方法
|
CN110452860A
(zh)
*
|
2019-09-24 |
2019-11-15 |
厦门大学 |
一种唾液链球菌及其在治疗炎症性肠病药物中的应用
|
EP4117697A1
(en)
|
2020-03-13 |
2023-01-18 |
PrecisionBiotics Group Limited |
Bifidobacterium longum
|
TWI748395B
(zh)
*
|
2020-03-31 |
2021-12-01 |
豐華生物科技股份有限公司 |
緩解過敏以及提升運動表現之組合物及其用途
|
CN113943681B
(zh)
*
|
2020-11-12 |
2023-07-04 |
江南大学 |
一株降低炎症反应且具有缓解便秘作用的长双歧杆菌
|
KR102307603B1
(ko)
*
|
2020-11-13 |
2021-10-05 |
주식회사 비피도 |
비피도박테리움 롱검 rapo (kctc13773bp)를 포함하는 암 예방 또는 치료용 조성물
|
CN114317310B
(zh)
*
|
2021-03-31 |
2023-09-22 |
江苏蓝泽生物科技有限公司 |
一种抗过敏的婴儿双歧杆菌制剂及其制备方法
|
CN114558037B
(zh)
*
|
2022-02-24 |
2023-08-15 |
同济大学 |
Akk和ls在制备提高认识水平的抗衰老产品中的应用
|
CN115725456B
(zh)
*
|
2022-10-11 |
2024-06-21 |
四川大学 |
一种唾液乳杆菌及其应用
|